(CII) BlackRock Enhanced Capital - Overview
Fund: Equity, Derivatives, Closed-End Fund
Dividends
| Dividend Yield | 17.37% |
| Yield on Cost 5y | 32.86% |
| Yield CAGR 5y | 36.91% |
| Payout Consistency | 92.2% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 17.6% |
| Relative Tail Risk | 4.07% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.24 |
| Alpha | 17.27 |
| Character TTM | |
|---|---|
| Beta | 0.866 |
| Beta Downside | 0.958 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.05% |
| CAGR/Max DD | 0.92 |
Description: CII BlackRock Enhanced Capital January 21, 2026
BlackRock Enhanced Capital and Income Closed Fund (NYSE:CII) is a U.S.-based closed-end fund that employs a derivative-income strategy, aiming to generate current income through options, futures, and other derivative instruments while maintaining exposure to a diversified portfolio of fixed-income securities.
As of the most recent filing (Q4 2024), the fund reported assets under management of roughly $1.2 billion, an annualized distribution yield near 7.5 %, and an expense ratio of 0.85 %. Its performance is closely tied to the shape of the yield curve and credit-spread dynamics, with higher yields on corporate bonds and a steepening curve generally boosting income from its option-writing activities.
Key macro drivers include Federal Reserve policy on interest rates, which influences both the underlying bond portfolio and the pricing of the derivatives used for income generation; a tightening credit market can also compress spreads, affecting the fund’s risk-adjusted returns. For a deeper dive into how CII’s derivative exposure aligns with current market conditions, consider exploring ValueRay’s analytical tools.
What is the price of CII shares?
Over the past week, the price has changed by -0.73%, over one month by -0.90%, over three months by +6.92% and over the past year by +30.24%.
Is CII a buy, sell or hold?
What are the forecasts/targets for the CII price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 32.7 | 41.6% |
CII Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 888.2m USD (888.2m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 888.2m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 888.2m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.11% (E(888.2m)/V(888.2m) * Re(9.11%) + (debt-free company))
Discount Rate = 9.11% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)